Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sustainable Development01:43

Sustainable Development

14.8K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
14.8K
Development of the Lymphatic System01:15

Development of the Lymphatic System

2.0K
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
2.0K
Language Development01:22

Language Development

877
Children master language quickly and with relative ease, supported by both biological predisposition and reinforcement. B. F. Skinner (1957) proposed that language is learned through reinforcement, while Noam Chomsky (1965) argued that language acquisition mechanisms are biologically determined.
The critical period for language acquisition suggests that the ability to acquire language is at its peak early in life. As people age, this proficiency decreases. Language development begins very...
877
Development of the Heart01:27

Development of the Heart

2.2K
The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
2.2K
Development of Immunocompetence01:22

Development of Immunocompetence

807
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
807
Fruit Development, Structure, and Function01:58

Fruit Development, Structure, and Function

25.1K
Fruits form from a mature flower ovary. As seeds develop from the ovules contained within, the ovary wall undergoes a series of complex changes to form fruit. In some fruits, such as soybeans, the ovary wall dries; in other fruits, such as grapes, it remains fleshy. In some cases, organs other than the ovary contribute to fruit formation; such fruits are called accessory fruits.
25.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minimum Margins After Positive Mohs Surgery Stages Correlate With Histologic Facing Loss.

Journal of drugs in dermatology : JDD·2026
Same author

HF Radar Signatures and Their Use for Target Classification, Recognition and Identification.

Sensors (Basel, Switzerland)·2026
Same author

Disseminated classic Kaposi sarcoma.

Clinical and experimental dermatology·2026
Same author

Papulonodular Eruption of the Lower Limbs in an Adult Woman: Answer.

The American Journal of dermatopathology·2026
Same author

Papulonodular Eruption of the Lower Limbs in an Adult Woman: Challenge.

The American Journal of dermatopathology·2026
Same author

Paediatric-Onset Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum: Is It a Different Disease?

Experimental dermatology·2026
Same journal

The external clinical teaching visit: GP supervisor engagement and perceptions of utility.

Australian journal of general practice·2026
Same journal

Time to re-examine penicillin allergy in Australian general practice.

Australian journal of general practice·2026
Same journal

No place like home: The role of general practitioners in a housing crisis.

Australian journal of general practice·2026
Same journal

Expanding Medicare access for treating opioid dependence.

Australian journal of general practice·2026
Same journal

How to thrive in general practice training: A practical guide.

Australian journal of general practice·2026
Same journal

The VETERANS lens: A new tool to enhance consultations with veteran patients.

Australian journal of general practice·2026
See all related articles

Related Experiment Video

Updated: Jan 23, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.8K

Cutaneous melanoma: Latest developments.

Anthony J Dixon1, Howard K Steinman2, Alexander Nirenberg3

  • 1PhD, MBBS, FACRRM, MAOCD, Director of Education, Australasian College of Cutaneous Oncology, Docklands, Vic; Honorary Professor, American Osteopathic College of Dermatology, Kirksville, Missouri, USA.

Australian Journal of General Practice
|June 21, 2019
PubMed
Summary
This summary is machine-generated.

New melanoma treatments, including BRAF inhibitors and programmed cell death protein 1 medications, offer improved survival rates and fewer side effects than ipilimumab for high-risk patients. Sentinel lymph node biopsy and ultrasonography with fine needle aspiration aid in melanoma assessment.

More Related Videos

Dual-mode Imaging of Cutaneous Tissue Oxygenation and Vascular Function
11:35

Dual-mode Imaging of Cutaneous Tissue Oxygenation and Vascular Function

Published on: December 8, 2010

16.9K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.1K

Related Experiment Videos

Last Updated: Jan 23, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.8K
Dual-mode Imaging of Cutaneous Tissue Oxygenation and Vascular Function
11:35

Dual-mode Imaging of Cutaneous Tissue Oxygenation and Vascular Function

Published on: December 8, 2010

16.9K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.1K

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Background:

  • High-risk melanoma patients face significant mortality.
  • Recent advancements in systemic therapies offer new hope.

Purpose of the Study:

  • To review novel melanoma medications.
  • To outline their efficacy, benefits, and risks.
  • To discuss the role of sentinel lymph node biopsy (SLNB) and ultrasonography with fine needle aspiration (US-FNA) in melanoma management.

Main Methods:

  • Review of current literature on melanoma pharmacotherapy.
  • Analysis of clinical trial data for new agents.
  • Evaluation of diagnostic procedures for nodal staging.

Main Results:

  • Ipilimumab shows limited efficacy with severe adverse events.
  • BRAF inhibitors offer improved efficacy and safety, particularly when combined with MEK inhibitors, but require BRAF mutation.
  • Programmed cell death protein 1 (PD-1) inhibitors demonstrate superior efficacy and tolerability compared to ipilimumab.
  • Both SLNB and US-FNA detect nodal involvement; US-FNA is safer.

Conclusions:

  • Novel agents like BRAF inhibitors and PD-1 inhibitors represent significant progress in melanoma treatment.
  • Treatment selection depends on patient-specific factors, including BRAF mutation status.
  • SLNB and US-FNA are valuable tools for accurate melanoma staging.